Other Resources
The Laboratory’s Role in Improving C. difficile Rates
Executive Dialogue
Clostridioides Difficile Rates Plummet At One Health System With Laboratory-Driven Redesign
In the fight against Clostridioides difficile (C. diff; formerly known as Clostridium difficile), hospitals have become extra vigilant about rapidly diagnosing and treating infected patients, which can save lives as well as prevent the spread of the infection. Yet, as AMITA Health Saint Francis Hospital Evanston (Ill.) learned, this approach can backfire if laboratory testing is overly sensitive, leading to high numbers of false positives and unnecessary treatment of patients who might have C. diff-like symptoms (e.g., diarrhea, abdominal cramps) but don’t have the infection. After the hospital redesigned laboratory testing for C. diff, cases declined by 54% and related costs decreased significantly.
Key Resources
Related Resources
Action Alert
Special Bulletin
Hospital Associations and Hospitals File Lawsuit Challenging Federal Rule That Ties Providers’ Hands
AHA Center for Health Innovation Market Scan
AHA Center for Health Innovation Market Scan